Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ANDERSON v. POLYMEDIX, INC. et al
Case Number:
2:12-cv-03721
Court:
Nature of Suit:
Other Statutes: Securities/Commodities
Multi Party Litigation:
Class Action
Judge:
Firms
-
March 24, 2015
Attys Want 33% Slice Of $1M Pie In PolyMedix Stock Suit
The lead plaintiff in an investor class action against now-bankrupt experimental drug company PolyMedix Inc. asked a Pennsylvania federal judge on Monday to approve a $1.15 million settlement with nearly $400,000 in attorneys' fees.
-
July 02, 2012
PolyMedix Hid Drug's Flaws Before $20M Stock Deal, Suit Says
PolyMedix Inc. was slapped with a lawsuit in Pennsylvania federal court Monday by a putative class of investors who say the experimental drug company misled the public about a flawed anti-stroke treatment in order to generate buzz for a $20 million stock offering.